Following the Veeva-Salesforce split, the life sciences industry is undergoing significant changes in the base Customer Relationship Management (CRM) platform and associated technology tools and platforms. Additionally, enterprises seek a unified approach to engage customers across the drug development lifecycle. This approach necessitates providers to upgrade their existing offerings and introduce novel products and platforms. In response, Salesforce announced the launch of its life sciences engagement platform, Salesforce Life Sciences Cloud. This platform offers different customer engagement modules across clinical and commercial segments.
In this report, we examine Salesforce’s current market position, key product announcements, and industry objectives. The report also reviews the Salesforce Life Sciences Cloud and covers essential issues and objectives around customer engagement for life sciences enterprises.
Scope
- Industry: life sciences (biopharmaceuticals and medical devices)
- Geography: global
- Service: life sciences technology
Contents
In this report, we examine:
- Key enterprise issues and objectives for life sciences engagement platforms
- Salesforce’s current positioning in the market
- Overview of Salesforce Life Sciences Cloud announcement
- Everest Group’s review of Salesforce Life Sciences Cloud
Membership(s)
Application Services
Banking and Financial Services Information Technology
Clinical Development Technology
Cloud and Infrastructure Services
Cybersecurity
Data & Analytics
Digital Services
Digital Workplace
Enterprise Platform Services (EPS)
Healthcare Payer and Provider Information Technology
Insurance Information Technology
Interactive Experience (IX) Services
Life Sciences Information Technology
Retail and CPG IT Services
Sustainability Technology and Services
Sourcing and Vendor Management
